Search





Search





Markets
/
Stocks
/
goss
/

Gossamer Bio Inc

GOSS

Add to Watchlist

0.205USD

+0.005+2.66%

Close 07-28 16:00（ET）Quotes delayed by 15 min

48.04MMarket Cap

LossP/E TTM

Gossamer Bio Inc

0.205

+0.005+2.66%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

GOSS Income Statement

You can find the annual or quarterly income statement of Gossamer Bio Inc here for insights into the performance and operational efficiency of Gossamer Bio Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

Total revenue

71.45%16.95M

47.13%13.80M

40.23%13.29M

-88.01%11.49M

--9.89M

--9.38M

--9.48M

--95.84M

----

Revenue

71.45%16.95M

47.13%13.80M

40.23%13.29M

-88.01%11.49M

--9.89M

--9.38M

--9.48M

--95.84M

----

Operating expenses

32.38%61.82M

31.49%59.84M

26.57%54.93M

14.85%50.25M

11.30%46.70M

16.60%45.51M

7.18%43.40M

-5.47%43.76M

-12.45%41.96M

-28.18%39.03M

-27.70%40.49M

-14.06%46.28M

-11.77%47.93M

5.22%54.34M

0.64%56.01M

-3.10%53.86M

2.16%54.32M

-5.73%51.65M

4.42%55.65M

10.41%55.58M

1.94%53.17M

1.11%54.79M

6.62%53.29M

11.00%50.34M

57.99%52.16M

36.13%54.19M

19.69%49.99M

261.75%45.35M

531.54%33.02M

4684.50%39.81M

--41.76M

--12.54M

--5.23M

--832.00K

R&D expenses

13.23%43.08M

35.51%48.94M

30.50%45.54M

18.49%41.58M

17.44%38.04M

20.49%36.11M

11.85%34.90M

-3.37%35.09M

-14.30%32.39M

-27.80%29.97M

-29.90%31.20M

-14.73%36.31M

-10.70%37.80M

1.41%41.51M

3.05%44.51M

-3.92%42.58M

1.18%42.32M

5.20%40.93M

3.21%43.19M

14.56%44.32M

1.00%41.83M

-8.65%38.91M

4.23%41.85M

8.43%38.68M

65.77%41.41M

64.64%42.60M

112.91%40.15M

349.89%35.68M

852.10%24.98M

3732.89%25.87M

--18.86M

--7.93M

--2.62M

--675.00K

Depreciation, depletion, and amortization

-98.54%5.00K

-94.44%6.00K

-97.22%6.00K

-98.00%6.00K

14.00%342.00K

-64.00%108.00K

-46.00%216.00K

-40.00%300.00K

-34.78%300.00K

-13.04%400.00K

8.70%500.00K

10.62%500.00K

2.68%460.00K

2.22%460.00K

7.98%460.00K

8.65%452.00K

22.74%448.00K

23.29%450.00K

21.71%426.00K

26.44%416.00K

25.00%365.00K

45.42%365.00K

70.73%350.00K

94.67%329.00K

117.91%292.00K

100.80%251.00K

540.63%205.00K

2716.67%169.00K

--134.00K

--125.00K

--32.00K

--6.00K

--0.00

Operating profit

-21.89%-44.87M

-27.44%-46.04M

-22.76%-41.64M

-174.42%-38.77M

12.27%-36.81M

7.43%-36.13M

16.23%-33.92M

212.54%52.09M

12.45%-41.96M

28.18%-39.03M

27.70%-40.49M

14.06%-46.28M

11.77%-47.93M

-5.22%-54.34M

-0.64%-56.01M

3.10%-53.86M

-2.16%-54.32M

5.73%-51.65M

-4.42%-55.65M

-10.41%-55.58M

-1.94%-53.17M

-1.11%-54.79M

-6.62%-53.29M

-11.00%-50.34M

-57.99%-52.16M

-36.13%-54.19M

-19.69%-49.99M

-261.75%-45.35M

-531.54%-33.02M

-4684.50%-39.81M

---41.76M

---12.54M

---5.23M

---832.00K

Net non-operating interest income (expenses)

Non-operating interest income

20.41%354.00K

--447.00K

59.77%687.00K

-69.01%542.00K

-14.53%294.00K

----

6.17%430.00K

151.65%1.75M

-41.40%344.00K

-47.81%310.00K

-12.90%405.00K

131.67%695.00K

162.05%587.00K

151.69%594.00K

143.46%465.00K

112.77%300.00K

16.06%224.00K

-93.14%236.00K

--191.00K

--141.00K

--193.00K

--3.44M

----

1078.65%1.05M

--698.00K

--626.00K

--307.00K

--89.00K

--0.00

Non-operating interest expense

0.33%2.75M

-20.99%2.75M

0.51%2.75M

-5.90%2.74M

-12.24%2.75M

7.50%3.48M

-18.22%2.73M

-14.96%2.92M

-10.60%3.13M

-6.31%3.24M

-3.80%3.34M

-1.49%3.43M

0.95%3.50M

-29.98%3.46M

-28.92%3.48M

-27.99%3.48M

-27.47%3.47M

-28.85%4.94M

23.99%4.89M

170.96%4.83M

--4.78M

--6.94M

--3.94M

--1.78M

----

--19.00K

-96.61%4.00K

--1.00K

--7.00K

--0.00

--118.00K

Special income (expenses)

----

--1.00K

---7.48M

----

100.00%0.00

----

100.00%0.00

-66566.67%-10.00M

100.00%0.00

0.00%-15.00K

25.00%-15.00K

0.00%-15.00K

33.33%-20.00K

99.72%-15.00K

94.55%-15.00K

99.90%-15.00K

98.93%-30.00K

-231.25%-5.30M

---275.00K

-1400.00%-15.00M

-180.50%-2.81M

---1.60M

100.00%0.00

95.12%-1.00M

95.21%-1.00M

100.00%0.00

---8.26M

---20.50M

---20.90M

---5.50M

Other non-operating income (expenses)

-77.02%603.00K

-75.62%1.02M

-31.11%2.95M

-1.93%2.69M

-6.82%2.62M

9.53%4.17M

25.38%4.29M

-57.98%2.75M

66.63%2.82M

161.54%3.81M

1130.12%3.42M

1013.80%6.54M

949.25%1.69M

1766.67%1.46M

-388.70%-332.00K

28.45%587.00K

-233.56%-199.00K

107.65%78.00K

138.33%115.00K

80.63%457.00K

-83.31%149.00K

-193.58%-1.02M

-120.19%-300.00K

-86.33%253.00K

137.50%893.00K

241.69%1.09M

49633.33%1.49M

--1.85M

--376.00K

--319.00K

---3.00K

----

--0.00

Income before tax

-27.37%-46.66M

-33.54%-47.33M

-51.00%-48.22M

-171.32%-38.27M

12.62%-36.64M

26.40%-35.44M

20.18%-31.93M

226.29%53.67M

14.72%-41.93M

13.66%-48.15M

32.60%-40.01M

24.74%-42.50M

14.92%-49.16M

0.92%-55.76M

1.47%-59.36M

5.63%-56.47M

-0.25%-57.78M

12.88%-56.28M

-4.21%-60.25M

10.52%-59.83M

-6.60%-57.64M

-18.11%-64.60M

-19.20%-57.81M

-50.28%-66.87M

-65.82%-54.07M

-41.00%-54.70M

1.83%-48.50M

-35.93%-44.50M

-25.25%-32.61M

-501.46%-38.79M

---49.40M

---32.74M

---26.04M

---6.45M

Income tax

----

96.35%-88.00K

100.00%0.00

-100.00%0.00

----

---2.41M

---1.13M

--4.43M

----

Income after tax

-27.37%-46.66M

-43.02%-47.24M

-56.55%-48.22M

-177.74%-38.27M

12.62%-36.64M

31.40%-33.03M

23.01%-30.80M

215.85%49.23M

14.72%-41.93M

13.66%-48.15M

32.60%-40.01M

24.74%-42.50M

14.92%-49.16M

0.92%-55.76M

1.47%-59.36M

5.63%-56.47M

-0.25%-57.78M

12.88%-56.28M

-4.21%-60.25M

10.52%-59.83M

-6.60%-57.64M

-18.11%-64.60M

-19.20%-57.81M

-50.28%-66.87M

-65.82%-54.07M

-41.00%-54.70M

1.83%-48.50M

-35.93%-44.50M

-25.25%-32.61M

-501.46%-38.79M

---49.40M

---32.74M

---26.04M

---6.45M

Net income from continuous operations

-27.37%-46.66M

-43.02%-47.24M

-56.55%-48.22M

-177.74%-38.27M

12.62%-36.64M

31.40%-33.03M

23.01%-30.80M

215.85%49.23M

14.72%-41.93M

13.66%-48.15M

32.60%-40.01M

24.74%-42.50M

14.92%-49.16M

0.92%-55.76M

1.47%-59.36M

5.63%-56.47M

-0.25%-57.78M

12.88%-56.28M

-4.21%-60.25M

10.52%-59.83M

-6.60%-57.64M

-18.11%-64.60M

-19.20%-57.81M

-50.28%-66.87M

-65.82%-54.07M

-41.00%-54.70M

1.83%-48.50M

-35.93%-44.50M

-25.25%-32.61M

-501.46%-38.79M

---49.40M

---32.74M

---26.04M

---6.45M

Net income attributable to controlling interests

-27.37%-46.66M

-43.02%-47.24M

-56.55%-48.22M

-177.74%-38.27M

12.62%-36.64M

31.40%-33.03M

23.01%-30.80M

215.85%49.23M

14.72%-41.93M

13.66%-48.15M

32.60%-40.01M

24.74%-42.50M

14.92%-49.16M

0.92%-55.76M

1.47%-59.36M

5.63%-56.47M

-0.25%-57.78M

12.88%-56.28M

-4.21%-60.25M

10.52%-59.83M

-6.60%-57.64M

-18.11%-64.60M

-19.20%-57.81M

-50.28%-66.87M

-65.82%-54.07M

-41.00%-54.70M

1.83%-48.50M

-35.93%-44.50M

-25.25%-32.61M

-501.46%-38.79M

---49.40M

---32.74M

---26.04M

---6.45M

Net income attributable to common shareholders

-27.37%-46.66M

-43.02%-47.24M

-56.55%-48.22M

-177.74%-38.27M

12.62%-36.64M

31.40%-33.03M

23.01%-30.80M

215.85%49.23M

14.72%-41.93M

13.66%-48.15M

32.60%-40.01M

24.74%-42.50M

14.92%-49.16M

0.92%-55.76M

1.47%-59.36M

5.63%-56.47M

-0.25%-57.78M

12.88%-56.28M

-4.21%-60.25M

10.52%-59.83M

-6.60%-57.64M

-18.11%-64.60M

-19.20%-57.81M

-50.28%-66.87M

-65.82%-54.07M

-41.00%-54.70M

1.83%-48.50M

-35.93%-44.50M

-25.25%-32.61M

-501.46%-38.79M

---49.40M

---32.74M

---26.04M

---6.45M

Basic earnings per share

-23.38%-0.20

-39.70%-0.20

-55.42%-0.21

-177.38%-0.17

13.03%-0.16

31.52%-0.15

34.39%-0.14

148.88%0.22

64.16%-0.19

63.97%-0.21

68.14%-0.21

39.55%-0.45

31.94%-0.52

20.65%-0.59

18.95%-0.65

8.08%-0.74

2.13%-0.76

15.59%-0.74

-0.38%-0.80

20.20%-0.80

10.96%-0.78

1.07%-0.88

-0.24%-0.80

-35.98%-1.00

-76.49%-0.87

-69.30%-0.89

-2.25%-0.80

-42.72%-0.74

-20.31%-0.50

-416.61%-0.53

---0.78

---0.52

---0.41

---0.10

Diluted earnings per share

-23.38%-0.20

-39.70%-0.20

-55.42%-0.21

-181.59%-0.17

13.03%-0.16

31.52%-0.15

34.39%-0.14

146.36%0.21

64.16%-0.19

63.97%-0.21

68.14%-0.21

39.55%-0.45

31.94%-0.52

20.65%-0.59

18.95%-0.65

8.08%-0.74

2.13%-0.76

15.59%-0.74

-0.38%-0.80

20.20%-0.80

10.96%-0.78

1.07%-0.88

-0.24%-0.80

-35.98%-1.00

-76.49%-0.87

-69.30%-0.89

-2.25%-0.80

-42.72%-0.74

-20.31%-0.50

-416.61%-0.53

---0.78

---0.52

---0.41

---0.10

Dividend per share

--0.00

Currency unit

--USD

Audit opinions

----

FAQs

How do I read Gossamer Bio Inc's income statement on TradingKey?



Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.

What is the difference between quarterly and annual income statements?



A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.

What does YOY mean on the income statement page?



YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.

Which income statement metrics matter most when analyzing GOSS stock?



Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.

What was Gossamer Bio Inc's revenue at year end?



Gossamer Bio Inc reported 48.47M in revenue for fiscal year 2025, up from 114.70M in the previous year.

How much revenue did Gossamer Bio Inc report in the most recent quarter?



Gossamer Bio Inc reported 16.95M in revenue for the most recent quarter, an increase of 71.45% year over year.

What was Gossamer Bio Inc's net income for the year?



Gossamer Bio Inc posted -170.37M in net income for fiscal year 2025.

How much net income did Gossamer Bio Inc post in the last quarter?



Gossamer Bio Inc reported -46.66M in net income for the latest quarter。

What was Gossamer Bio Inc's annual operating profit?



Gossamer Bio Inc's operating income was -163.25M for fiscal year 2025.

How is EPS related to the income statement?



EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.